The experimental drug reduced flare-ups for patients with chronic obstructive pulmonary disease, Astra said Friday..
Share this article
Earnings
Score 85
Bullish
AstraZeneca stock jumps 4% after surprise trial win for lung disease drug where rivals have failed
Mar 27, 2026 12:54 UTC
AZN, XLV, IHF, SPY
Short term
Related Articles
Score 85
Bearish
Here’s Why Netflix (NFLX) Fell Over 20% in Q4
Mar 27, 14:36
Score 82
Bearish
CrowdStrike Slides 7% Today as Earnings Disappoint and AI Rivals Intensify Pressure
Mar 27, 14:29
Score 25
International ETFs: EEM and IEFA Offer Distinct Global ETF Choices
Mar 27, 14:28
Score 65
Netflix Tests Subscriber Loyalty With Price Increases
Mar 27, 14:23
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.